Inter Biosolutions ApS: Financial statements 2024
CVR: 43014757
Inter Biosolutions ApS (CVR 43014757) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -886,041 and a net result of DKK -485,946 compared with DKK -14,614 the year before. Equity amounted to DKK -466,871.
- Gross Profit
- -886,041 kr.
- Profit/Loss
- -485,946 kr.
- Equity
- -466,871 kr.
- Total Assets
- 1,008,129 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -886 t. | -486 t. | -467 t. | - |
| 2023 | 0 | -19 t. | -15 t. | 19 t. | - |
| 2022 | 0 | -8 t. | -8 t. | 34 t. | - |
How creditworthy is Inter Biosolutions ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
As of October 9, 2024, Klaus Hjortenberg Kroll is registered as director of Inter Biosolutions ApS.
As of October 9, 2024, Carsten Pedersen Rise has stepped down as director of Inter Biosolutions ApS.
As of October 9, 2024, Kobo ApS is registered as an owner of Inter Biosolutions ApS with an ownership share of 66%.
Inter Biosolutions ApS has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK -14,614.
About Inter Biosolutions ApS
Inter Biosolutions ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Inter Biofuel ApS. The management consists of Klaus Hjortenberg Kroll. The company is owned by STEEN BRUMMERSTEDT IVERSEN ApS and Kobo ApS. In 2025, the company reported a gross profit of DKK 1,732,251 and a net result of DKK -1,516,000 compared with DKK -485,946 the year before. Equity amounted to DKK 1,017,129.
